Contents

CNS & Neurological Disorders - Drug Targets , Volume 5 - Number 1

Editorial [Hot Topic: Dopaminergic Neurotransmission (Guest Editor: Remco H.S. Westerink)]

, 5(1): 1

Remco H.S. Westerink


DOI: 10.2174/187152706784111524




Dopamine Receptor Pharmacology: Interactions with Serotonin Receptors and Significance for the Aetiology and Treatment of Schizophrenia

, 5(1): 3 - 23

J. C. Glennon, W. J. Wadman, A. C. McCreary and T. R. Werkman


DOI: 10.2174/187152706784111614




The Dopamine D3 Receptor: A Therapeutic Target for the Treatment of Neuropsychiatric Disorders

, 5(1): 25 - 43

L. Leriche, E. Bezard, C. Gross, O. Guillin, B. L. Foll, J. Diaz and P. Sokoloff


DOI: 10.2174/187152706784111551




Molecular Biology, Pharmacology and Functional Role of the Plasma Membrane Dopamine Transporter

, 5(1): 45 - 56

Raul R. Gainetdinov, Marc G. Caron, Jean-Martin Beaulieu and Tatyana D. Sotnikova


DOI: 10.2174/187152706784111579




Targeting Exocytosis: Ins and Outs of the Modulation of Quantal Dopamine Release

, 5(1): 57 - 77

Remco H.S. Westerink


DOI: 10.2174/187152706784111597




Excitability of Dopamine Neurons: Modulation and Physiological Consequences

, 5(1): 79 - 97

F. J. White, X- T. Hu, M. Marinelli and C. N. Rudick


DOI: 10.2174/187152706784111542




Phasic Dopamine Signaling During Behavior, Reward, and Disease States

, 5(1): 99 - 108

R. M. Wightman and M. L.A.V. Heien


DOI: 10.2174/187152706784111605




Dopamine and the Diseased Brain

, 5(1): 109 - 131

T. Kienast and A. Heinz


DOI: 10.2174/187152706784111560




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science